Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies

by Daniel J. O’Shannessy, Hongyue Dai, Melissa Mitchell, Shane Huntsman, Stephen Brantley, David Fenstermacher, Damon R. Reed
Published 2016-01-01

Developing a Prototype System for Integrating Pharmacogenomics Findings into Clinical Practice

by Casey Lynnette Overby, Peter Tarczy-Hornoch, Ira J. Kalet, Kenneth E. Thummel, Joe W. Smith, Guilherme Del Fiol, David Fenstermacher, Emily Beth Devine
Published 2012-11-01

Clonal architectures and driver mutations in metastatic melanomas.

by Li Ding, Minjung Kim, Krishna L Kanchi, Nathan D Dees, Charles Lu, Malachi Griffith, David Fenstermacher, Hyeran Sung, Christopher A Miller, Brian Goetz, Michael C Wendl, Obi Griffith, Lynn A Cornelius, Gerald P Linette, Joshua F McMichael, Vernon K Sondak, Ryan C Fields, Timothy J Ley, James J Mulé, Richard K Wilson, Jeffrey S Weber
Published 2014-01-01